Sofinnova Management VIII’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$24.7M Hold
481,270
13.51% 4
2017
Q3
$42.9M Sell
481,270
-211,858
-31% -$18.9M 26.16% 1
2017
Q2
$41.4M Sell
693,128
-6,302
-0.9% -$376K 23.2% 2
2017
Q1
$37.3M Sell
699,430
-205,556
-23% -$11M 19.68% 3
2016
Q4
$45.2M Buy
+904,986
New +$45.2M 25.41% 2